Zobrazeno 1 - 10
of 84
pro vyhledávání: '"D.A. van Kessel"'
Publikováno v:
Transplantation Reports, Vol 5, Iss 1, Pp - (2020)
Introduction: Lung transplantation (LTx) is a last treatment option for patients with an end-stage pulmonary disease. Although the monocyte-macrophage lineage is accepted to be clinically important only little is known about the effect of immunosuppr
Externí odkaz:
https://doaj.org/article/8e92ea061b224c77bedda5dfab5a4d57
Disseminated Nocardia infection: spontaneous resolution in response to decrease of immunosuppression
Publikováno v:
New Microbes and New Infections, Vol 3, Iss C, Pp 10-11 (2015)
Externí odkaz:
https://doaj.org/article/7130e762faa3474badffed9f16a13413
Autor:
Douwe H. Biesma, Karin M. Kazemier, C H M van Moorsel, Jan C. Grutters, D.A. van Kessel, Thijs W. Hoffman
Publikováno v:
Lung. 199:667-676
Idiopathic pulmonary fibrosis (IPF) is a severe fibrotic lung disease, in which inflammation is thought to only play a secondary role. Several factors associated with acute exacerbations of IPF (AE-IPF) have been identified, including infections. Thi
Publikováno v:
Expert Review of Vaccines. 19:227-234
Introduction: This review analyzes the efficacy of pneumococcal vaccinations in lung transplant patients before and after transplantation.Areas covered: This review addresses the risk for respiratory infections, in particular pneumococcal infections,
Autor:
Bart Luijk, Naftali Kaminski, M. Krebber, J.D. Herazo Maya, Q. Li, J.C. Grutters, Kevin Budding, Tineke Kardol-Hoefnagel, D.A. van Kessel, Henderikus G. Otten
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S155-S156
Purpose Long term survival after lung transplantation (LTx) is still determined by the occurrence of chronic lung allograft dysfunction (CLAD). Early identification of high risk patients for CLAD is a large clinial unmet need. Previously, we used gen
Autor:
R. Schramm, Jens Gottlieb, P. Evrard, Robin Vos, Geert Verleden, Christian Witt, J. M. Kwakkel-vanErp, Bart Luijk, J. M. A. Smits, Christiane Knoop, Frank Langer, Leonard Seghers, Dave Green, Rogier A.S. Hoek, Roland Buhl, D. Hoefer, G. Lang, K. Hoetzenecker, D.A. van Kessel, Tobias Deuse, Erik A M Verschuuren, B. Rondelet, G. Laufer
Publikováno v:
The Journal of heart and lung transplantation :the official publication of the International Society for Heart Transplantation, 39 (4
Journal of Heart and Lung Transplantation, 39(4), S375-S376. ELSEVIER SCIENCE INC
Journal of Heart and Lung Transplantation, 39(4), S375-S376. ELSEVIER SCIENCE INC
PURPOSE: Following introduction of the lung allocation score (LAS) in 2011, Eurotransplant member centers can apply for an exceptional LAS (eLAS) if the calculated LAS insufficiently reflects the perceived transplant benefit for a patient, specifical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cefb253edab12dff051126e76e373976
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/308983
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/308983
Publikováno v:
Transplantation Reports, Vol 5, Iss 1, Pp-(2020)
Introduction: Lung transplantation (LTx) is a last treatment option for patients with an end-stage pulmonary disease. Although the monocyte-macrophage lineage is accepted to be clinically important only little is known about the effect of immunosuppr
Autor:
Bob Meek, G.T. Rijkers, B.A.W. de Jong, R.C.L. Geever, D.A. van Kessel, Willem Jan W. Bos, Gertjan H.J. Wagenvoort, Jan C. Grutters, Bart J.M. Vlaminckx
Publikováno v:
Vaccine. 35(37)
Objectives The goal of this study is to investigate the immune response to the 13-valent pneumococcal conjugate vaccine (PCV13) in former pneumococcal CAP patients. We hypothesize that an impaired or suboptimal humoral immune response against (specif
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.